Mr. John Zehner This is Me

 View all 23 references Web References

1. 1. www.shaazamstocks.com

   www.shaazamstocks.com/profiles - [Cached]

   Published on: 8/15/2008   Last Visited: 8/15/2008

   John ZehnerPresident, Positron Pharmaceuticals
   
   Mr. Zehner has over 14 years of experience in the Nuclear Medicine field.John has been part of several start-ups, mergers and acquisitions.In 1993, he assisted in the start-up of Northern Virginia Isotopes, Inc., a nuclear pharmacy focused on distributing radioactive pharmaceuticals for diagnostics and therapy to the Washington D.C. market.In 1994, he established Valley Isotopes, Inc., a nuclear pharmacy in Winchester, Virginia, Inc.In 1995, John led the formation of Eastern Isotopes, Inc. through the merger of three nuclear pharmacies and later established its pharmaceutical manufacturing division for FDG in 1998.In 1999, he became President and COO of Eastern Isotopes, Inc. and under his leadership grew sales from approximately $4 million to over $34 million by 2003.In 2004, Mr. Zehner led the extremely lucrative sale of Eastern Isotopes, Inc. to IBA, SA, a Belgium life science company.

2. 2. Virginia Economic Development Partnership

   www.yesvirginia.com/About_Us/N - [Cached]

   Published on: 7/11/2006   Last Visited: 7/11/2006

   John Zehner, Owner
   
   Eastern Isotopes, Inc.
   
   (703) 819-9180
   ...
   "We are excited to be expanding in Virginia," said John Zehner, owner of Eastern Isotopes.

3. 3. www.engelpub.com

   www.engelpub.com/News/index.cf - [Cached]

   Published on: 6/12/2008   Last Visited: 6/16/2008

   John Zehner, President and Founder of NukeMed, Inc. and Dose Shield Corporation, has been named as President and Director of Positron Pharmaceuticals.
   ...
   Our products fully complement each other," said John Zehner, President and Founder of NukeMed, Inc. and Dose Shield Corporation.Zehner also stated, "We believe Positron is in an ideal position to offer a complete turnkey service into the Nuclear Cardiology market.
   ...
   In addition, Mr. Zehner executed a three year employment agreement with Positron to head Positron Pharmaceuticals.